Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 68
2001 182
2002 197
2003 209
2004 205
2005 253
2006 307
2007 317
2008 242
2009 293
2010 302
2011 307
2012 396
2013 454
2014 540
2015 696
2016 684
2017 660
2018 654
2019 634
2020 181
Text availability
Article attribute
Article type
Publication date

Search Results

7,379 results
Results by year
Filters applied: . Clear all
Page 1
Digital pathology and artificial intelligence.
Niazi MKK, Parwani AV, Gurcan MN. Niazi MKK, et al. Lancet Oncol. 2019 May;20(5):e253-e261. doi: 10.1016/S1470-2045(19)30154-8. Lancet Oncol. 2019. PMID: 31044723 Review.
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, Brenner B, Kakkar A, Rafii H, Solymoss S, Brilhante D, Monreal M, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. Farge D, et al. Lancet Oncol. 2019 Oct;20(10):e566-e581. doi: 10.1016/S1470-2045(19)30336-5. Epub 2019 Sep 3. Lancet Oncol. 2019. PMID: 31492632 Review.
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders.
Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos MV, Lonial S, Joao C, Anderson KC, GarcĂ­a-Sanz R, Riva E, Du J, van de Donk N, Berdeja JG, Terpos E, Zamagni E, Kyle RA, San Miguel J, Goldschmidt H, Giralt S, Kumar S, Raje N, Ludwig H, Ocio E, Schots R, Einsele H, Schjesvold F, Chen WM, Abildgaard N, Lipe BC, Dytfeld D, Wirk BM, Drake M, Cavo M, Lahuerta JJ, Lentzsch S. Hillengass J, et al. Lancet Oncol. 2019 Jun;20(6):e302-e312. doi: 10.1016/S1470-2045(19)30309-2. Lancet Oncol. 2019. PMID: 31162104 Review.
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial.
West H, McCleod M, Hussein M, Morabito A, Rittmeyer A, Conter HJ, Kopp HG, Daniel D, McCune S, Mekhail T, Zer A, Reinmuth N, Sadiq A, Sandler A, Lin W, Ochi Lohmann T, Archer V, Wang L, Kowanetz M, Cappuzzo F. West H, et al. Lancet Oncol. 2019 Jul;20(7):924-937. doi: 10.1016/S1470-2045(19)30167-6. Epub 2019 May 20. Lancet Oncol. 2019. PMID: 31122901
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Liang W, et al. Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14. Lancet Oncol. 2020. PMID: 32066541 No abstract available.
Carcinogenicity of night shift work.
IARC Monographs Vol 124 group. IARC Monographs Vol 124 group. Lancet Oncol. 2019 Aug;20(8):1058-1059. doi: 10.1016/S1470-2045(19)30455-3. Epub 2019 Jul 4. Lancet Oncol. 2019. PMID: 31281097 No abstract available.
Correction to Lancet Oncol 2019; 20: 1544-55.
Lancet Oncol. 2019 Dec;20(12):e663. doi: 10.1016/S1470-2045(19)30723-5. Lancet Oncol. 2019. PMID: 31797791 No abstract available.
Correction to Lancet Oncol 2019; 20: e522-34.
Lancet Oncol. 2019 Nov;20(11):e613. doi: 10.1016/S1470-2045(19)30638-2. Lancet Oncol. 2019. PMID: 31674319 No abstract available.
Correction to Lancet Oncol 2019; 20: 1506-517.
Lancet Oncol. 2019 Nov;20(11):e613. doi: 10.1016/S1470-2045(19)30646-1. Lancet Oncol. 2019. PMID: 31674317 No abstract available.
7,379 results
Jump to page
Feedback